Journal article
Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study.
- Abstract:
-
BACKGROUND: The median survival for patients with glioblastoma is reported to be 12 months. To improve the outcome for glioblastoma patients, the authors evaluated the therapeutic efficacy of preirradiation gemcitabine chemotherapy followed by standard radiotherapy. METHODS: Twenty-one patients with newly diagnosed glioblastoma were enrolled in a prospective unicenter trial of preirradiation gemcitabine chemotherapy. Chemotherapy included up to 4 monthly cycles of intravenous gemcitabine (Da...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Cancer
- Volume:
- 91
- Issue:
- 2
- Pages:
- 423-427
- Publication date:
- 2001-01-01
- DOI:
- EISSN:
-
1097-0142
- ISSN:
-
0008-543X
- Source identifiers:
-
241965
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:241965
- UUID:
-
uuid:a788f99b-d0d2-42d3-a896-8979e93ce922
- Local pid:
- pubs:241965
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2001
If you are the owner of this record, you can report an update to it here: Report update to this record